Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Longitude Capital is a venture capital firm founded in 2006, with offices located in Menlo Park, California, and Boston, Massachusetts. The firm focuses on venture growth investments in the healthcare sector, particularly in biotechnology, medical technology, and health solutions. Longitude Capital has raised over $2 billion across six funds, establishing a strong presence in the venture capital landscape.
Since its inception, Longitude Capital has built a diverse portfolio of over 75 companies, with more than 35 successful exits. The firm has demonstrated its ability to navigate various market cycles, consistently sourcing and managing investments that yield significant returns. Notable milestones include being a founding Series A investor in Aimmune Therapeutics, which went public in 2015 and was later acquired by Nestlé for $2.6 billion in 2020.
Longitude Capital invests in both privately held and publicly traded companies within the healthcare sector, emphasizing biotechnology, medical technology, and health solutions. Their investment strategy encompasses a balanced portfolio of clinical-stage and commercial-stage companies, focusing on clinically de-risked assets. The firm employs various investment structures, including traditional venture capital, asset spin-outs, recapitalizations, PIPEs, and royalties.
The firm targets investments across multiple stages, including pre-seed, seed, Series A, Series B, and growth equity. Longitude Capital seeks to improve clinical outcomes, enhance patient quality of life, and reduce the cost of care through its investments. Their approach is supported by extensive industry relationships and proprietary thematic research, which helps identify new investment opportunities.
Longitude Capital's portfolio includes a diverse range of companies in the healthcare sector. Notable investments include:
Juliet Bakker, Managing Director: Juliet has extensive experience in venture capital and healthcare investments, having previously worked at leading firms in the industry. She has a strong track record of successful investments in biotechnology and medical technology.
Maxwell Bikoff, Managing Director: Maxwell brings a wealth of knowledge in healthcare investing, with a focus on clinical-stage companies. His background includes significant roles in both venture capital and operational management within healthcare firms.
Patrick Enright, Managing Director: Patrick has a deep understanding of the healthcare landscape, with experience in both investment and operational roles. He has led numerous successful investments in transformative healthcare companies.
Marc Galletti, Managing Director: Marc specializes in identifying and nurturing innovative healthcare startups. His expertise spans various sectors within healthcare, including biotechnology and medical devices.
To pitch to Longitude Capital, founders should visit their website at longitudecapital.com or email mjamison@longitudecapital.com. A comprehensive pitch deck should include an overview of the business, market analysis, competitive landscape, and financial projections. Longitude Capital appreciates clarity and conciseness in presentations.
Response times can vary, but founders should expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In recent months, Longitude Capital has been active in the venture capital space, participating in 18 new investments and achieving 8 IPOs. The firm has also completed 4 mergers and acquisitions, further expanding its portfolio and demonstrating its commitment to growth in the healthcare sector.
Notable recent activities include the successful exit of Aimmune Therapeutics, which was acquired by Nestlé for $2.6 billion, and the acquisition of Bolt Medical by Boston Scientific. These exits highlight Longitude Capital's effective investment strategy and ability to identify high-potential companies.
What are Longitude Capital's investment criteria?
Longitude Capital invests in healthcare companies that focus on biotechnology, medical technology, and health solutions. They prefer companies with clinically de-risked assets and favorable valuations.
How can I apply or pitch to Longitude Capital?
Founders can pitch to Longitude Capital through their website at longitudecapital.com or by emailing mjamison@longitudecapital.com. A well-prepared pitch deck should include details about the business model, market opportunity, and team.
What makes Longitude Capital different from other venture firms?
Longitude Capital's deep expertise in the healthcare sector, combined with their diverse investment strategies and extensive industry relationships, allows them to provide valuable insights and support to portfolio companies.
What is Longitude Capital's geographic scope?
The firm primarily focuses on investments within North America, targeting both private and public healthcare companies.
What is the typical check size for investments?
Longitude Capital invests across various stages, including pre-seed, seed, Series A, Series B, and growth equity, with check sizes varying based on the stage and specific opportunity.
What kind of post-investment involvement does Longitude Capital have?
Longitude Capital actively supports its portfolio companies through strategic guidance, leveraging their extensive network and thematic research to help navigate market challenges and optimize growth strategies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.